Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RepleniSH: Levothyroxine in Subclinical Hypothyroidism Patients Undergoing CABG
NCT07380854Recruiting
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Feb 2022
- Primary completion
- Feb 2032
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Major Adverse Cardiovascular Events at 4 months. Started Feb 2022; status: recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT07380854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07380854.